Stocks TelegraphStocks Telegraph
Stock Ideas

RYZB Financial Statements and Analysis

NASDAQ : RYZB

RayzeBio, Inc. Common Stock

$62.49
0.01+0.02%
Open: 4:00 PM
Not Actively Trading

RYZB FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

RYZB Income Statement

A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

Date2023-09-30
reported currencyUSD
calendar year2023
periodQ3
revenue0
cost of revenue0
gross profit0
gross profit ratio0
research and development expenses18.17M
general and administrative expenses3.481M
selling and marketing expenses0
selling general and administrative expenses3.481M
other expenses-30.00K
operating expenses21.651M
cost and expenses21.651M
interest income3.49M
interest expense0
depreciation and amortization500.00K
ebitda-21.151M
ebitda ratio0
operating income-21.651M
operating income ratio0
total other income expenses net-30.00K
income before tax-18.191M
income before tax ratio0
income tax expense-3.49M
net income-18.191M
net income ratio0
eps-1.18
eps diluted-1.18
weighted average shs out15.40M
weighted average shs out dil15.40M
Graph

RYZB Balance Sheet

Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

Date2023-09-302023-06-30
reported currencyUSDUSD
calendar year20232023
periodQ3Q2
cash and cash equivalents
short term investments
cash and short term investments
net receivables
inventory
other current assets
total current assets
property plant equipment net
goodwill
intangible assets
goodwill and intangible assets
long term investments
tax assets
other non current assets
total non current assets
other assets
total assets
account payables
short term debt
tax payables
deferred revenue
other current liabilities
total current liabilities
long term debt
deferred revenue non current
deferred tax liabilities non current
other non current liabilities
total non current liabilities
other liabilities
capital lease obligations
total liabilities
preferred stock
common stock
retained earnings
accumulated other comprehensive income loss
other total stockholders equity
total stockholders equity
total equity
total liabilities and stockholders equity
minority interest
total investments
total debt
net debt
Graph

RYZB Cash Flow

A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

Date2023-09-30
reported currencyUSD
calendar year2023
periodQ3
deferred income tax-2.269M
stock based compensation2.564M
change in working capital67.00K
accounts receivables0
inventory0
accounts payables0
other working capital67.00K
other non cash items66.00K
net cash provided by operating activities-17.263M
investments in property plant and equipment-13.524M
acquisitions net0
purchases of investments-117.014M
sales maturities of investments55.00M
other investing activites0
net cash used for investing activites-75.538M
debt repayment0
common stock issued0
common stock repurchased0
dividends paid0
other financing activites0
net cash used provided by financing activities311.552M
effect of forex changes on cash0
net change in cash218.751M
cash at end of period252.303M
cash at beginning of period33.552M
operating cashflow-17.263M
capital expenditure-13.524M
free cash flow-30.787M
Graph

Frequently Asked Questions

How did RayzeBio, Inc. Common Stock do last quarter? What was its Total Revenue and Cost of Revenue?

A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, RYZB generated $0.00 in revenue last quarter, while its costs came in at $0.00.

Last quarter, how much Gross Profit did RayzeBio, Inc. Common Stock report?

A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. RayzeBio, Inc. Common Stock reported a $0.00 Gross Profit for the quarter ended Sep 30, 2023.

Have RYZB's Total Operating Expenses and Operating Income been favorable recently?

Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. RYZB incurred $21.65M worth of Operating Expenses, while it generated -$21.65M worth of Operating Income.

How much Net Income has RYZB posted recently?

The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from RayzeBio, Inc. Common Stock, the company generated -$18.19M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.

At the end of the last quarter, how much Cash and Equivalents did RayzeBio, Inc. Common Stock have?

The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to RayzeBio, Inc. Common Stock as of the end of the last quarter was -.

What are RYZB's Total Net Receivables for the last quarter?

Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, RYZB had Total Net Receivables of -.

In terms of Total Assets and Current Assets, where did RayzeBio, Inc. Common Stock stand at?

An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of RYZB were -, while the Total Assets stand at -.

As of the last quarter, how much Total Debt did RayzeBio, Inc. Common Stock have?

The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of RYZB's debt was - at the end of the last quarter.

What were RYZB's Total Liabilities during the last reported quarter?

A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, RYZB reported total liabilities of -.

How much did RYZB's Working Capital change over the last quarter?

Working Capital Change for RYZB was $67.00K over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.

RYZB generated how much cash from operating activities?

An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. RYZB generated -$17.26M of Cash from Operating Activities during its recently reported quarter.

What was RYZB's latest reported Net Change in Cash?

An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. RYZB reported a $218.75M Net Change in Cash in the most recent quarter.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph